LLY

1,063.79

-1.23%↓

JNJ

222.81

-0.32%↓

ABBV

215.58

+1.54%↑

UNH

377.18

-0.59%↓

MRK

115.96

+0.86%↑

LLY

1,063.79

-1.23%↓

JNJ

222.81

-0.32%↓

ABBV

215.58

+1.54%↑

UNH

377.18

-0.59%↓

MRK

115.96

+0.86%↑

LLY

1,063.79

-1.23%↓

JNJ

222.81

-0.32%↓

ABBV

215.58

+1.54%↑

UNH

377.18

-0.59%↓

MRK

115.96

+0.86%↑

LLY

1,063.79

-1.23%↓

JNJ

222.81

-0.32%↓

ABBV

215.58

+1.54%↑

UNH

377.18

-0.59%↓

MRK

115.96

+0.86%↑

LLY

1,063.79

-1.23%↓

JNJ

222.81

-0.32%↓

ABBV

215.58

+1.54%↑

UNH

377.18

-0.59%↓

MRK

115.96

+0.86%↑

Home・Aktien・Lisata Therapeutics

L
Lisata Therapeutics

Open

3.43 -4.46

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

3.39

Max

3.63

Schlüsselkennzahlen
By Trading Economics
Einkommen	-1.5M -4.5M
Gewinnspanne	-2,954
Angestellte	21

Dividenden
By Dow Jones
Nächstes Ergebnis	6. Aug. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	182K 24M
Vorheriger Eröffnungskurs	7.89
Vorheriger Schlusskurs	3.43

Lisata Therapeutics Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

1. Juni 2026, 23:48 UTC

Market Talk

Nikkei May Rise on Optimism Over AI Demand -- Market Talk

1. Juni 2026, 23:38 UTC

Akquisitionen, Fusionen, Übernahmen

Google Seeks $80 Billion for AI Buildout; Berkshire Will Buy $10 Billion Stake -- WSJ

1. Juni 2026, 23:37 UTC

Market Talk

Oil Edges Higher; Trump Seeks to Quell Israel-Hezbollah Conflict -- Market Talk

1. Juni 2026, 23:01 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

1. Juni 2026, 23:01 UTC

Market Talk

Dexus Stuck in 'Too Hard' Basket -- Market Talk

1. Juni 2026, 22:08 UTC

Akquisitionen, Fusionen, Übernahmen

Alphabet to Issue $80 Billion of Equity for AI Buildout. Berkshire to Buy $10 Billion. -- Barrons.com

1. Juni 2026, 22:01 UTC

Akquisitionen, Fusionen, Übernahmen

Alphabet to Issue $80 Billion of Equity for AI Buildout. Berkshire to Buy $10 Billion. -- Barrons.com

1. Juni 2026, 22:01 UTC

Akquisitionen, Fusionen, Übernahmen

Google Seeks to Raise $80 Billion for AI Infrastructure -- Update

1. Juni 2026, 21:55 UTC

Akquisitionen, Fusionen, Übernahmen

Greg Abel's Week Is Off to Quite a Start -- WSJ

1. Juni 2026, 21:53 UTC

Market Talk

Strong Earnings Suppress Concerns About Oil Market -- Market Talk

1. Juni 2026, 21:22 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Berkshire's Abel Takes Big Swing With Back-to-Back Deals -- Market Talk

1. Juni 2026, 20:50 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Tech, Media & Telecom Roundup: Market Talk

1. Juni 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

1. Juni 2026, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

1. Juni 2026, 20:46 UTC

Akquisitionen, Fusionen, Übernahmen

The Odds SpaceX Merges With Tesla Are Higher Than You Think -- Barrons.com

1. Juni 2026, 20:22 UTC

Akquisitionen, Fusionen, Übernahmen

Array Digital Infrastructure Doesn't Expect Additional Divs in 2026

1. Juni 2026, 20:21 UTC

Akquisitionen, Fusionen, Übernahmen

Array Digital Infrastructure Div Payable June 25 to Hldrs of Record June 11

1. Juni 2026, 20:21 UTC

Akquisitionen, Fusionen, Übernahmen

Array Digital Infrastructure Declares $11 Special Div

1. Juni 2026, 20:20 UTC

Akquisitionen, Fusionen, Übernahmen

Array Completes Sale of Select Spectrum Assets to Verizon for $1B

1. Juni 2026, 19:40 UTC

Market Talk

Remittances to Mexico Rise for Third Straight Month -- Market Talk

1. Juni 2026, 19:28 UTC

Market Talk

BoC Official Reiterates Need to Improve Business Investment -- Market Talk

1. Juni 2026, 19:01 UTC

Market Talk

Oil Futures Rise On Concerns About U.S.-Iran Talks -- Market Talk

1. Juni 2026, 18:58 UTC

Market Talk

U.S. Natural Gas Futures Snap 3-Session Winning Streak -- Market Talk

1. Juni 2026, 18:54 UTC

Akquisitionen, Fusionen, Übernahmen

Berkshire Stock Drops. Its Bargain-Priced Deal for Home Builder Fails to Impress Investors. -- Barrons.com

1. Juni 2026, 18:33 UTC

Market Talk

Mexican PMIs Show Sluggish Manufacturing in May -- Market Talk

1. Juni 2026, 18:32 UTC

Market Talk

Precious Metals Fall to Start June -- Market Talk

1. Juni 2026, 18:00 UTC

Akquisitionen, Fusionen, Übernahmen

Marsh McLennan Agency Completes Acquisition Of TriBridge Partners >MRSH

1. Juni 2026, 17:18 UTC

Market Talk

Global Asset Managers Accumulate Canadian Government Debt -- Market Talk

1. Juni 2026, 17:18 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

1. Juni 2026, 17:10 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Salesforce Estimated to Get $225M Sales Boost From Contentful -- Market Talk

Peer-Vergleich

Kursveränderung

Lisata Therapeutics Prognose

Rating-Konsens

By TipRanks

Neutral

1 ratings

Buy

Halten

Sell

Basierend auf 1 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Lisata Therapeutics – Dist abgegeben haben.

Finanzen

Vertriebs- und Verwaltungskosten

Gewinn vor Steuern

Verkäufe

Betriebsergebnis

Über Lisata Therapeutics

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.